ERBB2 and neoplasm: Similarly, a high tumor–to–contralateral site ratio (14.4 at 2 h, 2,000-μg dose) for patient 16 prompted the reevaluation of her biopsy samples using a FISH analysis, which actually suggested a HER2-positive tumor.